Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Tuberculosis | Research article

Incidence and predictors of tuberculosis among HIV-positive adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: a retrospective record review

Authors: Belisty Temesgen, Getiye Dejenu Kibret, Nakachew Mekonnen Alamirew, Mamaru Wubale Melkamu, Yitbarek Tenaw Hibstie, Pammla Petrucka, Animut Alebel

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Tuberculosis is the leading cause of morbidity and mortality among people living with human immunodeficiency virus. Almost one-third of deaths among people living with human immunodeficiency virus are attributed to tuberculosis. Despite this evidence, in Ethiopia, there is a scarcity of information regarding the incidence and predictors of tuberculosis among people living with HIV. Thus, this study assessed the incidence and predictors of tuberculosis among HIV-positive adults on antiretroviral therapy.

Methods

This study was a retrospective record review including 544 HIV-positive adults on antiretroviral therapy at Debre Markos Referral Hospital between January 1, 2012 and December 31, 2017. The study participants were selected using a simple random sampling technique. The data extraction format was adapted from antiretroviral intake and follow-up forms. Cox-proportional hazards regression model was fitted and Cox-Snell residual test was used to assess the goodness of fit. Tuberculosis free survival time was estimated using the Kaplan-Meier survival curve. Both the bi-variable and multivariable Cox-proportional hazard regression models were used to identify predictors of tuberculosis.

Results

In the final analysis, a total of 492 HIV-positive adults were included, of whom, 83 (16.9%) developed tuberculosis at the time of follow-up. This study found that the incidence of tuberculosis was 6.5 (95% CI: 5.2, 8.0) per 100-person-years (PY) of observation. Advanced World Health Organization clinical disease stage (III and IV) (AHR: 2.1, 95% CI: 1.2, 3.2), being ambulatory and bedridden (AHR: 1.8, 95% CI: 1.1, 3.1), baseline opportunistic infections (AHR: 2.8, 95% CI: 1.7, 4.4), low hemoglobin level (AHR: 3.5, 95% CI: 2.1, 5.8), and not taking Isonized Preventive Therapy (AHR: 3.9, 95% CI: 1.9, 7.6) were found to be the predictors of tuberculosis.

Conclusion

The study found that there was a high rate of tuberculosis occurrence as compared to previous studies. Baseline opportunistic infections, being ambulatory and bedridden, advanced disease stage, low hemoglobin level, and not taking Isonized Preventive Therapy were found to be the predictors of tuberculosis. Therefore, early detection and treatment of opportunistic infections like tuberculosis should get a special attention.
Literature
1.
go back to reference Frehiwot N, Mizan K, Seble M, Fethia K, Tekalign M, Zelalem T. National guidelines for comprehensive HIV prevention, care and treatment. Addis Ababa: Ministry of Health; 2014. Frehiwot N, Mizan K, Seble M, Fethia K, Tekalign M, Zelalem T. National guidelines for comprehensive HIV prevention, care and treatment. Addis Ababa: Ministry of Health; 2014.
3.
go back to reference Lawn SD, Meintjes G, McIlleron H, Harries AD, Wood R. Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review. BMC Med. 2013;11(1):253.CrossRef Lawn SD, Meintjes G, McIlleron H, Harries AD, Wood R. Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review. BMC Med. 2013;11(1):253.CrossRef
5.
go back to reference Beauté J, Dara M, Pd C, Ehsani S, Gozalov O, Hovanesyan A, Ködmön C, Molnarova B, Boom M, van der Werf M. Tuberculosis surveillance and monitoring in Europe 2017; 2017. Beauté J, Dara M, Pd C, Ehsani S, Gozalov O, Hovanesyan A, Ködmön C, Molnarova B, Boom M, van der Werf M. Tuberculosis surveillance and monitoring in Europe 2017; 2017.
8.
go back to reference Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006;367(9514):926–37.CrossRef Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006;367(9514):926–37.CrossRef
9.
go back to reference Gao J, Zheng P, Fu H. Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One. 2013;8(5):e64915.CrossRef Gao J, Zheng P, Fu H. Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One. 2013;8(5):e64915.CrossRef
10.
go back to reference Manosuthi W, Wiboonchutikul S, Sungkanuparph S. Integrated therapy for HIV and tuberculosis. AIDS Res Ther. 2016;13(1):22.CrossRef Manosuthi W, Wiboonchutikul S, Sungkanuparph S. Integrated therapy for HIV and tuberculosis. AIDS Res Ther. 2016;13(1):22.CrossRef
11.
go back to reference Muthamia OG, Chege PM. Determinants of adherence to anti retroviral therapy among adults living with HIV in urban low income settings: a case of Kayole division in Nairobi County, Kenya. Survival. 2011;10:11. Muthamia OG, Chege PM. Determinants of adherence to anti retroviral therapy among adults living with HIV in urban low income settings: a case of Kayole division in Nairobi County, Kenya. Survival. 2011;10:11.
12.
go back to reference Lemos LA, Feijão AR, Gir E, MTG G. Quality of life aspects of patients with HIV/tuberculosis co-infection. Acta Paulista de Enfermagem. 2012;25(SPE1):41–7.CrossRef Lemos LA, Feijão AR, Gir E, MTG G. Quality of life aspects of patients with HIV/tuberculosis co-infection. Acta Paulista de Enfermagem. 2012;25(SPE1):41–7.CrossRef
13.
go back to reference Karambu S, Matiru V, Kiptoo M, Oundo J. Characterization and factors associated with diarrhoeal diseases caused by enteric bacterial pathogens among children aged five years and below attending Igembe District hospital, Kenya. Pan Afr Med J. 2013;16:37.CrossRef Karambu S, Matiru V, Kiptoo M, Oundo J. Characterization and factors associated with diarrhoeal diseases caused by enteric bacterial pathogens among children aged five years and below attending Igembe District hospital, Kenya. Pan Afr Med J. 2013;16:37.CrossRef
14.
go back to reference Alemu YM, Awoke W, Wilder-Smith A. Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case–control study. BMJ Open. 2016;6(4):e009058.CrossRef Alemu YM, Awoke W, Wilder-Smith A. Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case–control study. BMJ Open. 2016;6(4):e009058.CrossRef
15.
go back to reference Assebe LF, Reda HL, Wubeneh AD, Lerebo WT, Lambert SM. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study. BMC Public Health. 2015;15(1):346.CrossRef Assebe LF, Reda HL, Wubeneh AD, Lerebo WT, Lambert SM. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study. BMC Public Health. 2015;15(1):346.CrossRef
16.
go back to reference Dowdy DW, Golub JE, Saraceni V, Moulton LH, Cavalcante SC, Cohn S, Pacheco AG, Chaisson RE, Durovni B. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. J Acquir Immune Defic Syndr (1999). 2014;66(5):552.CrossRef Dowdy DW, Golub JE, Saraceni V, Moulton LH, Cavalcante SC, Cohn S, Pacheco AG, Chaisson RE, Durovni B. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. J Acquir Immune Defic Syndr (1999). 2014;66(5):552.CrossRef
17.
go back to reference Organization WH. The use of co-Trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children. Geneva: WHO Press; 2013. Organization WH. The use of co-Trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children. Geneva: WHO Press; 2013.
18.
go back to reference Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis. 2011;204(6):893–901.CrossRef Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis. 2011;204(6):893–901.CrossRef
19.
go back to reference Kassa A, Teka A, Shewaamare A, Jerene D. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg. 2012;106(6):363–70.CrossRef Kassa A, Teka A, Shewaamare A, Jerene D. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg. 2012;106(6):363–70.CrossRef
20.
go back to reference Ahmed A, Mekonnen D, Kindie M. Incidence and predictors of tuberculosis among adult people living with HIV/AIDS in Afar public health facilities, Northeast Ethiopia. AIDS. 2015;1:3–10. Ahmed A, Mekonnen D, Kindie M. Incidence and predictors of tuberculosis among adult people living with HIV/AIDS in Afar public health facilities, Northeast Ethiopia. AIDS. 2015;1:3–10.
21.
go back to reference Alene KA, Nega A, Taye BW. Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect Dis. 2013;13(1):292.CrossRef Alene KA, Nega A, Taye BW. Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect Dis. 2013;13(1):292.CrossRef
22.
go back to reference Dalbo M, Tamiso A. Incidence and predictors of tuberculosis among HIV/AIDS infected patients: a five-year retrospective follow-up study. Adv Infect Dis. 2016;6(02):70.CrossRef Dalbo M, Tamiso A. Incidence and predictors of tuberculosis among HIV/AIDS infected patients: a five-year retrospective follow-up study. Adv Infect Dis. 2016;6(02):70.CrossRef
23.
go back to reference Federal Democratic Republic of Ethiopia Ministry of Health. In: Ababa A, editor. National comprehensive Tuberculosis, Leprosy and TB/HIV training manual for Health Care Workers; 2016. Federal Democratic Republic of Ethiopia Ministry of Health. In: Ababa A, editor. National comprehensive Tuberculosis, Leprosy and TB/HIV training manual for Health Care Workers; 2016.
24.
go back to reference The Ethiopian Fedral MIinistry of Health. National ART guidlines for prevention, care and treatment: Ministry of health Ethiopia. Addis Ababa: 2017. The Ethiopian Fedral MIinistry of Health. National ART guidlines for prevention, care and treatment: Ministry of health Ethiopia. Addis Ababa: 2017.
25.
go back to reference Ministry of Health E: National Comprehensive HIV Care and Treatment Training for Health care Providers. 2014. Ministry of Health E: National Comprehensive HIV Care and Treatment Training for Health care Providers. 2014.
26.
go back to reference Saraceni V, Durovni B, Cavalcante SC, Cohn S, Pacheco AG, Moulton LH, Chaisson RE, Golub JE. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil. Braz J Infect Dis. 2014;18(5):491–5.CrossRef Saraceni V, Durovni B, Cavalcante SC, Cohn S, Pacheco AG, Moulton LH, Chaisson RE, Golub JE. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil. Braz J Infect Dis. 2014;18(5):491–5.CrossRef
27.
go back to reference Pathmanathan I, Dokubo EK, Shiraishi RW, Agolory SG, Auld AF, Onotu D, Odafe S, Dalhatu I, Abiri O, Debem HC. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012. PLoS One. 2017;12(3):e0173309.CrossRef Pathmanathan I, Dokubo EK, Shiraishi RW, Agolory SG, Auld AF, Onotu D, Odafe S, Dalhatu I, Abiri O, Debem HC. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012. PLoS One. 2017;12(3):e0173309.CrossRef
28.
go back to reference Enju L, Makubi A, Drain P, Spiegelman D, Sando D, Nan L, Chalamilla G, Sudfeld C, Hertzmark E, Fawzi W. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy in Tanzania. AIDS (London, England). 2015;29(11):1391.CrossRef Enju L, Makubi A, Drain P, Spiegelman D, Sando D, Nan L, Chalamilla G, Sudfeld C, Hertzmark E, Fawzi W. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy in Tanzania. AIDS (London, England). 2015;29(11):1391.CrossRef
29.
go back to reference Melkamu H, Seyoum B, Dessie Y. Determinants of tuberculosis infection among adult HIV positives attending clinical care in western Ethiopia: a case-control study. AIDS Res Treat. 2013;2013. Melkamu H, Seyoum B, Dessie Y. Determinants of tuberculosis infection among adult HIV positives attending clinical care in western Ethiopia: a case-control study. AIDS Res Treat. 2013;2013.
30.
go back to reference Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a south African cohort. Aids. 2005;19(18):2109–16.CrossRef Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a south African cohort. Aids. 2005;19(18):2109–16.CrossRef
31.
go back to reference Purohit V, Bora V, Ramdeo R, Rewari B. Immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy for HIV. J Indian Acad Clin Med. 2010;11(2):301–304. Purohit V, Bora V, Ramdeo R, Rewari B. Immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy for HIV. J Indian Acad Clin Med. 2010;11(2):301–304.
32.
go back to reference Bonnet MM, Pinoges LL, Varaine FF, Oberhauser BB, Do O’Brien D, Kebede YY, Hewison CC, Zachariah RR, Ferradini LL. Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden. Aids. 2006;20(9):1275–9.CrossRef Bonnet MM, Pinoges LL, Varaine FF, Oberhauser BB, Do O’Brien D, Kebede YY, Hewison CC, Zachariah RR, Ferradini LL. Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden. Aids. 2006;20(9):1275–9.CrossRef
33.
go back to reference Habtamu Oljira MI. Determinants of Active Tuberculosis among HIV-Positive Adults Attending Clinical Care in Ambo general hospital and Gedo hospital, West Shoa Zone, Oromia, Ethiopia (unmatched case-controlstudy). J Med Physiol Biophys. 2015;33(ISSN):2422–8427. Habtamu Oljira MI. Determinants of Active Tuberculosis among HIV-Positive Adults Attending Clinical Care in Ambo general hospital and Gedo hospital, West Shoa Zone, Oromia, Ethiopia (unmatched case-controlstudy). J Med Physiol Biophys. 2015;33(ISSN):2422–8427.
34.
go back to reference Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study. PLoS One. 2013;8(5):e64488.CrossRef Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study. PLoS One. 2013;8(5):e64488.CrossRef
35.
go back to reference Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV infected patients in Amhara region, Ethiopia. Afr Health Sci. 2016;16(2):588–95.CrossRef Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV infected patients in Amhara region, Ethiopia. Afr Health Sci. 2016;16(2):588–95.CrossRef
Metadata
Title
Incidence and predictors of tuberculosis among HIV-positive adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: a retrospective record review
Authors
Belisty Temesgen
Getiye Dejenu Kibret
Nakachew Mekonnen Alamirew
Mamaru Wubale Melkamu
Yitbarek Tenaw Hibstie
Pammla Petrucka
Animut Alebel
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7912-9

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue